These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26928228)

  • 1. Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.
    Dunning AM; Michailidou K; Kuchenbaecker KB; Thompson D; French JD; Beesley J; Healey CS; Kar S; Pooley KA; Lopez-Knowles E; Dicks E; Barrowdale D; Sinnott-Armstrong NA; Sallari RC; Hillman KM; Kaufmann S; Sivakumaran H; Moradi Marjaneh M; Lee JS; Hills M; Jarosz M; Drury S; Canisius S; Bolla MK; Dennis J; Wang Q; Hopper JL; Southey MC; Broeks A; Schmidt MK; Lophatananon A; Muir K; Beckmann MW; Fasching PA; Dos-Santos-Silva I; Peto J; Sawyer EJ; Tomlinson I; Burwinkel B; Marme F; Guénel P; Truong T; Bojesen SE; Flyger H; González-Neira A; Perez JI; Anton-Culver H; Eunjung L; Arndt V; Brenner H; Meindl A; Schmutzler RK; Brauch H; Hamann U; Aittomäki K; Blomqvist C; Ito H; Matsuo K; Bogdanova N; Dörk T; Lindblom A; Margolin S; Kosma VM; Mannermaa A; Tseng CC; Wu AH; Lambrechts D; Wildiers H; Chang-Claude J; Rudolph A; Peterlongo P; Radice P; Olson JE; Giles GG; Milne RL; Haiman CA; Henderson BE; Goldberg MS; Teo SH; Yip CH; Nord S; Borresen-Dale AL; Kristensen V; Long J; Zheng W; Pylkäs K; Winqvist R; Andrulis IL; Knight JA; Devilee P; Seynaeve C; Figueroa J; Sherman ME; Czene K; Darabi H; Hollestelle A; van den Ouweland AM; Humphreys K; Gao YT; Shu XO; Cox A; Cross SS; Blot W; Cai Q; Ghoussaini M; Perkins BJ; Shah M; Choi JY; Kang D; Lee SC; Hartman M; Kabisch M; Torres D; Jakubowska A; Lubinski J; Brennan P; Sangrajrang S; Ambrosone CB; Toland AE; Shen CY; Wu PE; Orr N; Swerdlow A; McGuffog L; Healey S; Lee A; Kapuscinski M; John EM; Terry MB; Daly MB; Goldgar DE; Buys SS; Janavicius R; Tihomirova L; Tung N; Dorfling CM; van Rensburg EJ; Neuhausen SL; Ejlertsen B; Hansen TV; Osorio A; Benitez J; Rando R; Weitzel JN; Bonanni B; Peissel B; Manoukian S; Papi L; Ottini L; Konstantopoulou I; Apostolou P; Garber J; Rashid MU; Frost D; ; Izatt L; Ellis S; Godwin AK; Arnold N; Niederacher D; Rhiem K; Bogdanova-Markov N; Sagne C; Stoppa-Lyonnet D; Damiola F; ; Sinilnikova OM; Mazoyer S; Isaacs C; Claes KB; De Leeneer K; de la Hoya M; Caldes T; Nevanlinna H; Khan S; Mensenkamp AR; ; Hooning MJ; Rookus MA; Kwong A; Olah E; Diez O; Brunet J; Pujana MA; Gronwald J; Huzarski T; Barkardottir RB; Laframboise R; Soucy P; Montagna M; Agata S; Teixeira MR; ; Park SK; Lindor N; Couch FJ; Tischkowitz M; Foretova L; Vijai J; Offit K; Singer CF; Rappaport C; Phelan CM; Greene MH; Mai PL; Rennert G; Imyanitov EN; Hulick PJ; Phillips KA; Piedmonte M; Mulligan AM; Glendon G; Bojesen A; Thomassen M; Caligo MA; Yoon SY; Friedman E; Laitman Y; Borg A; von Wachenfeldt A; Ehrencrona H; Rantala J; Olopade OI; Ganz PA; Nussbaum RL; Gayther SA; Nathanson KL; Domchek SM; Arun BK; Mitchell G; Karlan BY; Lester J; Maskarinec G; Woolcott C; Scott C; Stone J; Apicella C; Tamimi R; Luben R; Khaw KT; Helland Å; Haakensen V; Dowsett M; Pharoah PD; Simard J; Hall P; García-Closas M; Vachon C; Chenevix-Trench G; Antoniou AC; Easton DF; Edwards SL
    Nat Genet; 2016 Apr; 48(4):374-86. PubMed ID: 26928228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C6ORF97-ESR1 breast cancer susceptibility locus: influence on progression and survival in breast cancer patients.
    Yamamoto-Ibusuki M; Yamamoto Y; Fujiwara S; Sueta A; Yamamoto S; Hayashi M; Tomiguchi M; Takeshita T; Iwase H
    Eur J Hum Genet; 2015 Jul; 23(7):949-56. PubMed ID: 25370037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of functional genetic variants at 6q25.1 and risk of breast cancer in a Chinese population.
    Wang Y; He Y; Qin Z; Jiang Y; Jin G; Ma H; Dai J; Chen J; Hu Z; Guan X; Shen H
    Breast Cancer Res; 2014 Aug; 16(4):422. PubMed ID: 25116933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.
    Li Y; Li Y; Wedrén S; Li G; Charn TH; Desai KV; Bonnard C; Czene K; Humphreys K; Darabi H; Einarsdóttir K; Heikkinen T; Aittomäki K; Blomqvist C; Chia KS; Nevanlinna H; Hall P; Liu ET; Liu J
    Breast Cancer Res; 2011 Jan; 13(1):R10. PubMed ID: 21269472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ESR1 is co-expressed with closely adjacent uncharacterised genes spanning a breast cancer susceptibility locus at 6q25.1.
    Dunbier AK; Anderson H; Ghazoui Z; Lopez-Knowles E; Pancholi S; Ribas R; Drury S; Sidhu K; Leary A; Martin LA; Dowsett M
    PLoS Genet; 2011 Apr; 7(4):e1001382. PubMed ID: 21552322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent ESR1-CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancers.
    Veeraraghavan J; Tan Y; Cao XX; Kim JA; Wang X; Chamness GC; Maiti SN; Cooper LJ; Edwards DP; Contreras A; Hilsenbeck SG; Chang EC; Schiff R; Wang XS
    Nat Commun; 2014 Aug; 5():4577. PubMed ID: 25099679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic role of recurrent ESR1-CCDC170 gene fusions in breast cancer endocrine resistance.
    Li L; Lin L; Veeraraghavan J; Hu Y; Wang X; Lee S; Tan Y; Schiff R; Wang XS
    Breast Cancer Res; 2020 Aug; 22(1):84. PubMed ID: 32771039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Protein Encoded by the CCDC170 Breast Cancer Gene Functions to Organize the Golgi-Microtubule Network.
    Jiang P; Li Y; Poleshko A; Medvedeva V; Baulina N; Zhang Y; Zhou Y; Slater CM; Pellegrin T; Wasserman J; Lindy M; Efimov A; Daly M; Katz RA; Chen X
    EBioMedicine; 2017 Aug; 22():28-43. PubMed ID: 28687497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer risk-associated variants at 6q25.1 influence risk of hepatocellular carcinoma in a Chinese population.
    Li J; Wang Y; Zhu Y; Gong Y; Yang Y; Tian J; Zhang Y; Zou D; Peng X; Ke J; Gong J; Zhong R; Chang J
    Carcinogenesis; 2017 Apr; 38(4):447-454. PubMed ID: 28334234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in the estrogen receptor alpha gene (ESR1), daily cycling estrogen and mammographic density phenotypes.
    Fjeldheim FN; Frydenberg H; Flote VG; McTiernan A; Furberg AS; Ellison PT; Barrett ES; Wilsgaard T; Jasienska G; Ursin G; Wist EA; Thune I
    BMC Cancer; 2016 Oct; 16(1):776. PubMed ID: 27717337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships of physical and breast cancer phenotypes with three single-nucleotide polymorphisms (rs2046210, rs3757318, and rs3803662) associated with breast cancer risk in Japanese women.
    Kawada K; Taira N; Mizoo T; Suzuki Y; Kajiwara Y; Hatono M; Tsukioki T; Kochi M; Abe Y; Nishiyama K; Iwamoto T; Ikeda H; Shien T; Doihara H; Ishihara S; Kawai H; Kawasaki K; Ishibe Y; Ogasawara Y; Toyooka S
    Breast Cancer; 2021 Mar; 28(2):478-487. PubMed ID: 33185851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Admixture mapping identifies a locus on 6q25 associated with breast cancer risk in US Latinas.
    Fejerman L; Chen GK; Eng C; Huntsman S; Hu D; Williams A; Pasaniuc B; John EM; Via M; Gignoux C; Ingles S; Monroe KR; Kolonel LN; Torres-Mejía G; Pérez-Stable EJ; Burchard EG; Henderson BE; Haiman CA; Ziv E
    Hum Mol Genet; 2012 Apr; 21(8):1907-17. PubMed ID: 22228098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of potential regulatory function of breast cancer risk locus at 6q25.1.
    Sun Y; Ye C; Guo X; Wen W; Long J; Gao YT; Shu XO; Zheng W; Cai Q
    Carcinogenesis; 2016 Feb; 37(2):163-168. PubMed ID: 26645718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide association study using family-based cohorts identifies the WLS and CCDC170/ESR1 loci as associated with bone mineral density.
    Mullin BH; Walsh JP; Zheng HF; Brown SJ; Surdulescu GL; Curtis C; Breen G; Dudbridge F; Richards JB; Spector TD; Wilson SG
    BMC Genomics; 2016 Feb; 17():136. PubMed ID: 26911590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC).
    Hein R; Maranian M; Hopper JL; Kapuscinski MK; Southey MC; Park DJ; Schmidt MK; Broeks A; Hogervorst FB; Bueno-de-Mesquita HB; Muir KR; Lophatananon A; Rattanamongkongul S; Puttawibul P; Fasching PA; Hein A; Ekici AB; Beckmann MW; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Sawyer E; Tomlinson I; Kerin M; Miller N; Marmee F; Schneeweiss A; Sohn C; Burwinkel B; Guénel P; Cordina-Duverger E; Menegaux F; Truong T; Bojesen SE; Nordestgaard BG; Flyger H; Milne RL; Perez JI; Zamora MP; Benítez J; Anton-Culver H; Ziogas A; Bernstein L; Clarke CA; Brenner H; Müller H; Arndt V; Stegmaier C; Rahman N; Seal S; Turnbull C; Renwick A; Meindl A; Schott S; Bartram CR; Schmutzler RK; Brauch H; Hamann U; Ko YD; ; Wang-Gohrke S; Dörk T; Schürmann P; Karstens JH; Hillemanns P; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Bogdanova NV; Zalutsky IV; Antonenkova NN; Bermisheva M; Prokovieva D; Farahtdinova A; Khusnutdinova E; Lindblom A; Margolin S; Mannermaa A; Kataja V; Kosma VM; Hartikainen J; Chen X; Beesley J; ; ; Lambrechts D; Zhao H; Neven P; Wildiers H; Nickels S; Flesch-Janys D; Radice P; Peterlongo P; Manoukian S; Barile M; Couch FJ; Olson JE; Wang X; Fredericksen Z; Giles GG; Baglietto L; McLean CA; Severi G; Offit K; Robson M; Gaudet MM; Vijai J; Alnæs GG; Kristensen V; Børresen-Dale AL; John EM; Miron A; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Andrulis IL; Knight JA; Glendon G; Mulligan AM; Figueroa JD; García-Closas M; Lissowska J; Sherman ME; Hooning M; Martens JW; Seynaeve C; Collée M; Hall P; Humpreys K; Czene K; Liu J; Cox A; Brock IW; Cross SS; Reed MW; Ahmed S; Ghoussaini M; Pharoah PD; Kang D; Yoo KY; Noh DY; Jakubowska A; Jaworska K; Durda K; Złowocka E; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Shen CY; Yu JC; Hsu HM; Hou MF; Orr N; Schoemaker M; Ashworth A; Swerdlow A; Trentham-Dietz A; Newcomb PA; Titus L; Egan KM; Chenevix-Trench G; Antoniou AC; Humphreys MK; Morrison J; Chang-Claude J; Easton DF; Dunning AM
    PLoS One; 2012; 7(8):e42380. PubMed ID: 22879957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of RMND1/CCDC170-ESR1 single nucleotide polymorphisms with hip fracture and osteoporosis in postmenopausal women.
    Hidalgo-Bravo A; Parra-Torres AY; Casas-Avila L; Jimenez-Ortega RF; Ramírez-Salazar EG; Patiño N; Rivera-Paredez B; Salmerón J; Valdés-Flores M; Velázquez-Cruz R
    Climacteric; 2019 Feb; 22(1):97-104. PubMed ID: 30601066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients.
    Martínez-Galán J; Torres-Torres B; Núñez MI; López-Peñalver J; Del Moral R; Ruiz De Almodóvar JM; Menjón S; Concha A; Chamorro C; Ríos S; Delgado JR
    BMC Cancer; 2014 Feb; 14():59. PubMed ID: 24495356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the Estrogen Receptor 1 Polymorphisms rs2046210 and rs9383590 with the Risk, Age at Onset and Prognosis of Breast Cancer.
    Miedl H; Oswald D; Haslinger I; Gstoettner M; Wenzl R; Proestling K; Schneeberger C; Yotova I; Schreiber M
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1.
    Zheng W; Long J; Gao YT; Li C; Zheng Y; Xiang YB; Wen W; Levy S; Deming SL; Haines JL; Gu K; Fair AM; Cai Q; Lu W; Shu XO
    Nat Genet; 2009 Mar; 41(3):324-8. PubMed ID: 19219042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.
    Fletcher O; Johnson N; Orr N; Hosking FJ; Gibson LJ; Walker K; Zelenika D; Gut I; Heath S; Palles C; Coupland B; Broderick P; Schoemaker M; Jones M; Williamson J; Chilcott-Burns S; Tomczyk K; Simpson G; Jacobs KB; Chanock SJ; Hunter DJ; Tomlinson IP; Swerdlow A; Ashworth A; Ross G; dos Santos Silva I; Lathrop M; Houlston RS; Peto J
    J Natl Cancer Inst; 2011 Mar; 103(5):425-35. PubMed ID: 21263130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.